Literature DB >> 12209696

Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: an interdisciplinary study on 107 cases.

Gerardo Ferrara1, Giuseppe Argenziano, H Peter Soyer, Rosamaria Corona, Francesco Sera, Bruno Brunetti, Lorenzo Cerroni, Sergio Chimenti, Laila El Shabrawi-Caelen, Angela Ferrari, Rainer Hofmann-Wellenhof, Steven Kaddu, Domenico Piccolo, Massimiliano Scalvenzi, Stefania Staibano, Ingrid H Wolf, Gaetano De Rosa.   

Abstract

BACKGROUND: Dermoscopy (dermatoscopy, epiluminescence microscopy) is increasingly employed for the preoperative detection of cutaneous melanoma; dermoscopic features of pigmented skin lesions have been previously defined using histopathology as the key to the code. In a preliminary study on 10 cases evaluated by nine dermoscopists and nine histopathologists, the authors experienced that when at least two dermoscopists disagree in evaluating a melanocytic lesion, even histopathologic consultations may give equivocal results.
METHODS: One hundred seven melanocytic skin lesions, consecutively excised because of equivocal clinical and/or dermoscopic features, were retrospectively examined by eight dermoscopists and eight histopathologists; the diagnostic interobserver agreement was calculated by means of the Schouten k statistics. After histopathologic consultations, all 107 lesions underwent unblinded dermoscopic re-evaluation in order to find which dermoscopic features had given rise to histopathologic diagnostic difficulties.
RESULTS: The interobserver ageement was good for both dermoscopy (k = 0.53) and histopathology (k = 0.74). Out of 48 cases evaluated by the dermoscopists in complete accordance, only 8 (16.7%) received at least one conflicting histopathologic diagnosis. Instead, among the remaining 59 cases with at least one disagreeing dermoscopic diagnosis, 21 (35.6%) received at least one disagreeing histopathologic diagnosis. The unblinded dermoscopic re-evaluation showed that five out of seven lesions with clear-cut regression structures were histopathologically controversial.
CONCLUSIONS: At least for selected and reasonably difficult lesions, a diagnostic discrepancy among formally trained dermoscopists seems to be predictive for a diagnostic disagreement among histopathologists. Lesions showing clear-cut regression structures are prone to give some histopathologic disagreement. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Year:  2002        PMID: 12209696     DOI: 10.1002/cncr.10768

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.

Authors:  Patricia A Carney; Lisa M Reisch; Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan Knezevich; Berta M Geller; Gary Longton; Joann G Elmore
Journal:  J Cutan Pathol       Date:  2016-07-01       Impact factor: 1.587

2.  Frequency of Publication of Dermoscopic Images in Inter-observer Studies: A Systematic Review.

Authors:  Sam Polesie; Oscar Zaar
Journal:  Acta Derm Venereol       Date:  2021-12-17       Impact factor: 3.875

3.  Melanocytic lesions ≤ 6mm: Prospective series of 481 melanocytic trunk and limb lesions in Brazil.

Authors:  Gabriella Campos-do-Carmo; Aretha Brito Nobre; Tullia Cuzzi; Giuseppe Argenziano; Carlos Gil Ferreira; Luiz Claudio Santos Thuler
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

4.  Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Rubeta N Matin; Kai Yuen Wong; Roger Benjamin Aldridge; Alana Durack; Abha Gulati; Sue Ann Chan; Louise Johnston; Susan E Bayliss; Jo Leonardi-Bee; Yemisi Takwoingi; Clare Davenport; Colette O'Sullivan; Hamid Tehrani; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

5.  Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Lavinia Ferrante di Ruffano; Rubeta N Matin; David R Thomson; Kai Yuen Wong; Roger Benjamin Aldridge; Rachel Abbott; Monica Fawzy; Susan E Bayliss; Matthew J Grainge; Yemisi Takwoingi; Clare Davenport; Kathie Godfrey; Fiona M Walter; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

6.  Definition of an automated Content-Based Image Retrieval (CBIR) system for the comparison of dermoscopic images of pigmented skin lesions.

Authors:  Alfonso Baldi; Raffaele Murace; Emanuele Dragonetti; Mario Manganaro; Oscar Guerra; Stefano Bizzi; Luca Galli
Journal:  Biomed Eng Online       Date:  2009-08-16       Impact factor: 2.819

7.  The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion.

Authors:  Anna Balato; Annunziata Raimondo; Mariateresa Cantelli; Maria Siano; Serena Lembo; Massimiliano Scalvenzi; Nicola Balato
Journal:  Dermatol Reports       Date:  2011-07-11

8.  Classifying dermoscopic patterns of naevi in a case-control study of melanoma.

Authors:  Seamus R McWhirter; David L Duffy; Katie J Lee; Glen Wimberley; Philip McClenahan; Natalie Ling; Marco Ardigo; Helmut Schaider; H Peter Soyer; Richard A Sturm
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

9.  The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms.

Authors:  Gerardo Ferrara; Zsolt Argenyi; Giuseppe Argenziano; Rino Cerio; Lorenzo Cerroni; Arturo Di Blasi; Elisa A A Feudale; Caterina M Giorgio; Cesare Massone; Oscar Nappi; Carlo Tomasini; Carmelo Urso; Iris Zalaudek; Harald Kittler; H Peter Soyer
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

10.  Routine Clinical-Pathologic Correlation of Pigmented Skin Tumors Can Influence Patient Management.

Authors:  Caterina Longo; Simonetta Piana; Aimilios Lallas; Elvira Moscarella; Mara Lombardi; Margherita Raucci; Giovanni Pellacani; Giuseppe Argenziano
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.